RETRACTED: MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4 (Retracted article. See vol. 25, 2022)

被引:27
作者
Tian, Yifu [1 ]
Fu, Xiaodan [1 ]
Li, Qingling [1 ]
Wang, Ying [2 ]
Fan, Dan [2 ]
Zhou, Qin [2 ]
Kuang, Weilu [2 ]
Shen, Liangfang [2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Oncol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
关键词
breast cancer; microRNA; protein sprouty homolog 4; proliferation; migration; invasion; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; EXPRESSION; MIGRATION; INVASION;
D O I
10.3892/mmr.2018.9572
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Numerous microRNAs (miRs) have been implicated in breast cancer; however, the molecular mechanism is not fully understood. The present study examined the function and regulatory mechanism of miR-181 in breast cancer. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to examine the RNA and protein expression. MTT assay, wound healing assay and transwell assay were conducted to study cell proliferation, migration and invasion. Luciferase reporter gene assay was used to confirm targeting relationship. The results suggested that the miR-181 expression levels were significantly higher in breast cancer cell lines and clinical tissue samples. The increased expression of miR-181 was markedly associated with higher clinical stage and lymph node metastasis. The patients with high miR-181 expression demonstrated worse prognosis compared with those with a low expression of miR-181. Small interfering RNA-induced miR-181 downregulation significantly inhibited breast cancer cell proliferation, migration and invasion in vitro, and tumor growth in vivo. Protein sprouty homolog 4 (SPRY4), downregulated in breast cancer tissues and cell lines, was observed to be a novel target gene of miR-181. Downregulation of SPRY4 was significantly associated with breast cancer progression in addition to poor prognosis. Knockdown of SPRY4 rescued the inhibitory effects of miR-181 downregulation on the malignant phenotypes of breast cancer cells. Thus, the present study demonstrated that miR-181 serves a promoting role in breast cancer at least in part through the inhibition of SPRY4 expression. The present results expand the understanding of the miR-181/SPRY4 axis' function during for the malignant progression of breast cancer.
引用
收藏
页码:5603 / 5613
页数:11
相关论文
共 29 条
  • [1] The functions of animal microRNAs
    Ambros, V
    [J]. NATURE, 2004, 431 (7006) : 350 - 355
  • [2] Oncogenic miR-181a/b afect the DNA damage response in aggressive breast cancer
    Bisso, Andrea
    Faleschini, Michela
    Zampa, Federico
    Capaci, Valeria
    De Santa, Jacopo
    Santarpia, Libero
    Piazza, Silvano
    Cappelletti, Vera
    Daidone, Mariagrazia
    Agami, Reuven
    Del Sal, Giannino
    [J]. CELL CYCLE, 2013, 12 (11) : 1679 - 1687
  • [3] miRNAs, cancer, and stem cell division
    Croce, CM
    Calin, GA
    [J]. CELL, 2005, 122 (01) : 6 - 7
  • [4] Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
    Jing, Hongyu
    Liaw, Lucy
    Friesel, Robert
    Vary, Calvin
    Hua, Shucheng
    Yang, Xuehui
    [J]. CANCER CELL INTERNATIONAL, 2016, 16
  • [5] Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells
    Koufaris, C.
    Valbuena, G. N.
    Pomyen, Y.
    Tredwell, G. D.
    Nevedomskaya, E.
    Lau, C-H E.
    Yang, T.
    Benito, A.
    Ellis, J. K.
    Keun, H. C.
    [J]. ONCOGENE, 2016, 35 (21) : 2766 - 2776
  • [6] SPRY4-mediated ERK1/2 signaling inhibition abolishes 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell
    Li, Mingjiang
    Zhang, Hui
    Zhao, Xingbo
    Yan, Lei
    Wang, Chong
    Li, Chunyan
    Li, Changzhong
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (08) : 600 - 604
  • [7] miR-1193 Suppresses Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting IGF2BP2
    Li, Xianglei
    Li, Yanhua
    Lu, Hong
    [J]. ONCOLOGY RESEARCH, 2017, 25 (04) : 579 - 585
  • [8] Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
    Liu, Rong
    Shi, Peiguo
    Nie, Zhi
    Liang, Huichun
    Zhou, Zhongmei
    Chen, Wenlin
    Chen, Haijun
    Dong, Chao
    Yang, Runxiang
    Liu, Suling
    Chen, Ceshi
    [J]. THERANOSTICS, 2016, 6 (04): : 533 - 544
  • [9] MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1
    Liu, Yun
    Hu, Xu
    Xia, Daokui
    Zhang, Songlin
    [J]. ONCOLOGY LETTERS, 2016, 12 (05) : 4181 - 4186
  • [10] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
    Livak, KJ
    Schmittgen, TD
    [J]. METHODS, 2001, 25 (04) : 402 - 408